This study aims to explore the potential of utilizing the RNFL thickness and serological concentrations of IL-18, irisin, CML, and RAGE as diagnostic indicators for Mild Cognitive Impairment (MCI) among individuals with T2DM. The gene discussed is IL18; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.